This report analyzes the worldwide market for catheters for the period of 2010 to 2017. The major product segments covered in this market study include Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Specialty Catheters, and Neurovascular Catheters. The report also describes the key influencing factors for the global and China catheters industry. Market analysis and forecasts are provided for the period 2010 through 2017.

• Definition, estimates & forecast of the global and China catheters market from 2010 to 2017
• Analysis of sub-segments for market
• Market forces driving and restraining the growth of the market
• Up-to-date analysis of the latest trends in the industry
• Acumen into the size and shape of the market growth

The in-depth research and high level analysis will allow catheters product manufacturers, service providers, marketing companies, research and development agencies to make informed decisions about catheters manufacturing, marketing, growth strategies and gaining competitive advantage.

• Leading industry opinion keeps you abreast of latest news and trends 
• Forward-looking outlook on a category, market or issue affecting the industry
• Latest six year forecast assesses how the market is predicted to develop 
• Make more informed business decisions from insightful and in-depth analysis of the market performance
• Obtain sales forecast for the period 2012 to 2017 for all the major markets

This research is specially designed to estimate and analyze the demand and performance of the global and China catheters market. The report covers all the major segments of catheters industry and provides in-depth analysis, market revenue, and trend analysis by segments and statistically refined forecast for the segments covered. 

• Cardiovascular Catheters
• Neurovascular Catheters
• Intravenous Catheters
• Urological Catheters
• Specialty Catheters

• North America
• Europe
• Asia-Pacific
• China
• Rest of the World (RoW)

The global catheter market is expected to reach USD 22.6 billion in 2012. Aging population in both developed and emerging markets, patient’s choice for minimally invasive procedures, and product innovations are key growth drivers for the market. The catheter devices market is segmented into cardiovascular, urological, neurovascular, intravenous and specialty catheters. Among all types of catheters, cardiovascular catheters account for about 40.9% of the global catheter market. 

Physical inactivity, obesity, diabetes and lifestyle are the major contributory factors for cardiovascular diseases. The growth in global cardiovascular catheter market is fuelled by newer and novel innovations in catheters that ensure swift movement and insertion capabilities. The U.S. leads the cardiovascular catheter market segment with about 36.7% market share in 2011. The global cardiovascular catheter market was worth about USD 8.3 billion in 2011, while global intravenous catheter segment revenue reached USD 2.5 billion in 2011, registering a double digit growth over 2010. The segment is expected to continue growing at similar pace during the forecast period (2012 – 2017).

North America is the largest market for catheters, wherein the U.S. medical device companies manufacture about 65% to 75% of catheter products that are being used worldwide. North America as a whole accounted for a market of USD 9.0 billion in 2011, which is forecasted to reach USD 10.0 billion in 2017. Asia-Pacific is the fastest growing market and is expected to grow with a double digit growth rate during the forecast period. This market is driven by the demand for low-cost catheters particularly in the urological segment.

Rising incidences of coronary disease and increased per capita healthcare expenditure in China has helped the growth of China catheter market. In 2011, the Chinese catheter market was valued at USD 0.7 billion and is expected to grow at a CAGR of 15.4% from 2011 to 2017 to reach a market value of 1.5 billion in 2017. The Chinese market is expected to be largely supported by the growth of cardiovascular segment

Globally, millions of people suffer from cardiovascular, urinary and other such diseases, which require incision procedures. Such procedures involve various medical devices including catheter. Catheter can be inserted into a body cavity, duct or vessel to allow drainage or administration of fluid or gasses. Growth in cardiac and urological diseases has triggered the demand for catheter devices. These devices can broadly be segmented into five categories including cardiovascular, intravenous, neurovascular, urological and specialty catheters.

Cardiovascular catheter is the largest market segment of the catheters market and accounts for about 2/5th of the market in 2011. The cardiovascular catheter is divided into seven sub segments, which includes 

• Interventional 
• Percutaneous Coronary Artery  (PTCA)
• Arthectomy 
• Ablation Electrophysiology 
• Diagnostic 
• Cardiac Angiography 
• Peripheral Angiography 

The worldwide cardiovascular catheters devices market is booming mainly due technological advancements to enhance the procedure and insertion capabilities by simplifying procedures. Advanced catheters reduce the risk of error, which is motivating the adoption of such devices among buyers.

In 2010, around 43 million children below five years of age were overweight. Obesity increases the risk for developing coronary artery disease, stroke and such other major cardiovascular ailments. The growth in obesity increases the number of cardiovascular procedures, intern increasing the consumption of cardiovascular catheters.

Source:  World Bank Income Group, Transparency Market Research

The U.S. leads the cardiovascular catheter market segment with about 36.7% market share in 2011. The global cardiovascular catheter market was worth about USD 8.3 billion in 2011.

Source: Transparency Market Research

Specialty catheter is the second largest segment in the global catheters market, while urological catheter market offers huge growth opportunities; as the market is expected to grow at a CAGR of 11.1% during 2010-2017. The growth in the market is attributed to rising incidence of urological problems and an aging global population. The advance catheterization techniques and superior devices are expected to shape the future growth of urological catheters market. Success for manufacturers lies in the development of advance catheters with reduced risk of infection, high durability of devices and less device malfunction rate. Moreover, continual shift has been observed in use of material towards polyurethane/polycarbonate materials such as carbothane. Such materials provide extra benefits such as higher strength, enhanced softness, minimal invasion and larger internal diameter. Further, market players are also required to address major catheter related issues such as thrombosis by developing advance devices in near future.

There has been consistence growth in central venous access devices over the last decade with about five million central venous catheters per year are used in the U.S. We estimate that the market for neurovascular catheters was worth about USD 1.8 billion in 2011 and expect this to reach USD xx.xx billion in 2017. The U.S., Europe and Japan accounted for nearly xx.x% of the global neurovascular catheters market, with the U.S. alone accounting for xx.x%.

North America is the largest market for catheters, wherein the U.S. medical device companies manufacture about 65% to 75% of catheter products that are being used worldwide. North America as a whole accounted for a market of USD 9.0 billion in 2011, which is forecasted to reach USD xx.xx billion in 2017. Asia-Pacific is the fastest growing market and is expected to grow with a double digit growth rate during the forecast period. This market is driven by the demand for low-cost catheters particularly in the urological segment.

Rising incidences of coronary disease and increased per capita healthcare expenditure in China has helped the growth of China catheter market. In 2011, the Chinese catheter market was valued at USD 0.7 billion and is expected to grow at a CAGR of xx.x% from 2011 to 2017 to reach a market value of xx.xx billion in 2017. The Chinese market is expected to be largely supported by the growth of cardiovascular segment.